文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症呼吸衰竭与机械通气

选择性消化道去污染与ICU机械通气患者院内死亡率的关联:系统评价与Meta分析

Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA · 2022-01-01
一句话结论在ICU机械通气成人中,与标准治疗或安慰剂相比,选择性消化道去污染(SDD)与较低的院内死亡率相关(RR 0.91,95%CrI 0.82-0.99;中等确定性)。

该系统评价与Meta分析检索MEDLINE、EMBASE和CENTRAL数据库至2022年9月,纳入32项随机临床试验共24389例ICU机械通气成人,比较SDD与标准治疗或安慰剂。30项试验共24034例参与者的主要结局分析显示,SDD组院内死亡率低于对照组(RR 0.91,95%CrI 0.82-0.99;I²=33.9%;中等确定性),SDD降低院内死亡率的后验概率为99.3%。亚组分析显示,含静脉抗菌药物的试验中SDD获益明显(RR 0.84,95%CrI 0.74-0.94),而不含静脉药物的试验中未见获益(RR 1.01,95%CrI 0.91-1.11;亚组交互作用P=.02)。SDD还与呼吸机相关性肺炎(RR 0.44,95%CrI 0.36-0.54)和ICU获得性菌血症(RR 0.68,95%CrI 0.57-0.81)风险降低相关;抗菌药物耐药菌阳性培养发生率的数据无法合并,证据确定性极低。

要点

  • 在ICU机械通气成人中,SDD与标准治疗或安慰剂相比降低院内死亡率(RR 0.91,95%CrI 0.82-0.99;中等确定性),降低院内死亡率的后验概率为99.3%。
  • SDD的获益仅在含静脉抗菌药物的试验中明显(RR 0.84,95%CrI 0.74-0.94),不含静脉药物的试验中未见获益(RR 1.01,95%CrI 0.91-1.11),亚组交互作用P=.02。
  • SDD与呼吸机相关性肺炎风险降低相关(RR 0.44,95%CrI 0.36-0.54)。
  • SDD与ICU获得性菌血症风险降低相关(RR 0.68,95%CrI 0.57-0.81)。
  • 关于SDD对 antimicrobial resistance 影响的证据确定性极低,现有数据无法合并。

适用人群与场景

  • 在ICU接受机械通气的成人;纳入的随机临床试验中参与者中位年龄54岁(IQR 44-60),女性参与者中位比例33%(IQR 25%-38%)。

研究设计与关键结果

  • 研究类型为系统评价与Meta分析,纳入32项随机临床试验共24389例参与者;主要结局分析来自30项试验共24034例参与者。
  • SDD与标准治疗或安慰剂相比,院内死亡率的合并估计风险比RR为0.91(95%CrI 0.82-0.99;I²=33.9%;中等确定性),SDD降低院内死亡率的后验概率为99.3%。
  • 亚组分析:含静脉抗菌药物的试验中RR为0.84(95%CrI 0.74-0.94),不含静脉抗菌药物的试验中RR为1.01(95%CrI 0.91-1.11),亚组间交互作用P=.02。
  • SDD与呼吸机相关性肺炎风险降低相关(RR 0.44,95%CrI 0.36-0.54)。
  • SDD与ICU获得性菌血症风险降低相关(RR 0.68,95%CrI 0.57-0.81)。
  • 关于抗菌药物耐药菌阳性培养发生率的数据无法合并,证据确定性极低。

证据类型、等级与局限

  • 证据类型为系统评价与Meta分析(纳入随机临床试验),主要结局证据确定性为中等。
  • 关于SDD对 antimicrobial resistance 影响的证据确定性极低。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在ICU机械通气成人中,与标准治疗或安慰剂相比,使用SDD与较低的院内死亡率相关,该关联在含静脉抗菌药物的试验中明显,在不含静脉抗菌药物的试验中未见。

指南或共识出处

  • JAMA发表的系统评价与Meta分析(检索MEDLINE、EMBASE和CENTRAL数据库至2022年9月)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The effectiveness of selective decontamination of the digestive tract (SDD) in critically ill adults receiving mechanical ventilation is uncertain.

OBJECTIVE: To determine whether SDD is associated with reduced risk of death in adults receiving mechanical ventilation in intensive care units (ICUs) compared with standard care.

DATA SOURCES: The primary search was conducted using MEDLINE, EMBASE, and CENTRAL databases until September 2022.

STUDY SELECTION: Randomized clinical trials including adults receiving mechanical ventilation in the ICU comparing SDD vs standard care or placebo.

DATA EXTRACTION AND SYNTHESIS: Data extraction and risk of bias assessments were performed in duplicate. The primary analysis was conducted using a bayesian framework.

MAIN OUTCOMES AND MEASURES: The primary outcome was hospital mortality. Subgroups included SDD with an intravenous agent compared with SDD without an intravenous agent. There were 8 secondary outcomes including the incidence of ventilator-associated pneumonia, ICU-acquired bacteremia, and the incidence of positive cultures of antimicrobial-resistant organisms.

RESULTS: There were 32 randomized clinical trials including 24 389 participants in the analysis. The median age of participants in the included studies was 54 years (IQR, 44-60), and the median proportion of female trial participants was 33% (IQR, 25%-38%). Data from 30 trials including 24 034 participants contributed to the primary outcome. The pooled estimated risk ratio (RR) for mortality for SDD compared with standard care was 0.91 (95% credible interval [CrI], 0.82-0.99; I2 = 33.9%; moderate certainty) with a 99.3% posterior probability that SDD reduced hospital mortality. The beneficial association of SDD was evident in trials with an intravenous agent (RR, 0.84 [95% CrI, 0.74-0.94]), but not in trials without an intravenous agent (RR, 1.01 [95% CrI, 0.91-1.11]) (P value for the interaction between subgroups = .02). SDD was associated with reduced risk of ventilator-associated pneumonia (RR, 0.44 [95% CrI, 0.36-0.54]) and ICU-acquired bacteremia (RR, 0.68 [95% CrI, 0.57-0.81]). Available data regarding the incidence of positive cultures of antimicrobial-resistant organisms were not amenable to pooling and were of very low certainty.

CONCLUSIONS AND RELEVANCE: Among adults in the ICU treated with mechanical ventilation, the use of SDD compared with standard care or placebo was associated with lower hospital mortality. Evidence regarding the effect of SDD on antimicrobial resistance was of very low certainty.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Hammond NE, Myburgh J, Seppelt I, et al. Association Between Selective Decontamination of the Digestive Tract and In-Hospital Mortality in Intensive Care Unit Patients Receiving Mechanical Ventilation: A Systematic Review and Meta-analysis. JAMA. 2022. PMID: 36286098. doi:10.1001/jama.2022.19709

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。